✨ Medicine Distribution Notices




1260 NEW ZEALAND GAZETTE, No. 48 10 MARCH 2005


Product:
Tramadol Hydrochloride
Active Ingredient:
Tramadol hydrochloride 50mg
Dosage Form:
Capsule
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Chanelle Medical Limited, Loughrea, County Galway, Ireland
Dated this 2nd day of March 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1326


Renewal of Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Mitomycin-C-Kyowa
Active Ingredient:
Mitomycin 10mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Company
Manufacturer:
Kyowa Hakko Kogyo Co Limited, Chiyoda-Ku, Tokyo, Japan
Note: This consent is valid for two years from 6 March 2005.

Product:
Mitomycin-C-Kyowa
Active Ingredient:
Mitomycin 2mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Company
Manufacturer:
Kyowa Hakko Kogyo Co Limited, Chiyoda-Ku, Tokyo, Japan
Note: This consent is valid for two years from 6 March 2005.

Product:
Mitomycin-C-Kyowa
Active Ingredient:
Mitomycin 20mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Company
Manufacturer:
Kyowa Hakko Kogyo Co Limited, Chiyoda-Ku, Tokyo, Japan
Note: This consent is valid for two years from 6 March 2005.

Product:
Rescriptor
Active Ingredient:
Delavirdine mesylate 100mg equivalent to 82.6mg delavirdine base
Dosage Form:
Film-coated tablet
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Pfizer Pharmaceuticals LLC, Arecibo, Puerto Rico
Note: This consent is valid for two years from 1 March 2005.
Dated this 2nd day of March 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1328


Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Fuzeon
Active Ingredient:
Enfuvirtide 108mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturers:
F Hoffmann-La Roche Limited, Basel, Switzerland
Pfizer Inc, Kalamazoo, Michigan, United States of America
Note: This consent is valid for two years from the date of publication of this notice.

Product:
Zevalin
Active Ingredient:
Ibritumomab tiuxetan 1.6mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Schering (NZ) Limited
Manufacturer:
Baxter Pharmaceutical Solutions LLC, Bloomington, Indiana, United States of America
Note: This consent is valid for two years from the date of publication of this notice.



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 48


Gazette.govt.nz PDF NZ Gazette 2005, No 48





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Tramadol Hydrochloride

πŸ₯ Health & Social Welfare
2 March 2005
Medicines, Distribution, Tramadol hydrochloride, AFT Pharmaceuticals Limited, Chanelle Medical Limited
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Renewal of Provisional Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
2 March 2005
Medicines, Distribution, Mitomycin-C-Kyowa, Rescriptor, Bristol-Myers Squibb (NZ) Company, Pfizer New Zealand Limited, Kyowa Hakko Kogyo Co Limited
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Provisional Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
2 March 2005
Medicines, Distribution, Fuzeon, Zevalin, Roche Products (New Zealand) Limited, Schering (NZ) Limited, F Hoffmann-La Roche Limited, Pfizer Inc, Baxter Pharmaceutical Solutions LLC
  • DON MATHESON, Deputy Director-General, Public Health